For: |
Wang Y, Wei L, Jiang D, Cong X, Fei R, Xiao J, Wang Y. |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i5/649.htm |
Number | Citing Articles |
1 |
Rong-Juan Pei, Xin-Wen Chen, Meng-Ji Lu. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways. World Journal of Gastroenterology 2014; 20(33): 11618-11629 doi: 10.3748/wjg.v20.i33.11618
|
2 |
X. B. Pan, L. Wei, H. S. Chen, F. Liu, Y. Gao. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Archives of Virology 2007; 152(6): 1159 doi: 10.1007/s00705-006-0927-4
|
3 |
L. J. Liu, J. H. Wang, S. C. Du, J. H. Tian, R. F. Yang, L. Wei. rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B. Journal of Viral Hepatitis 2010; 17(s1): 66 doi: 10.1111/j.1365-2893.2010.01273.x
|
4 |
M. A. Aslam, F. R. Awan, I. Tauseef, S. Ali, N. Ahmad, N. A. Malik, M. N. Riaz, J. A. Qureshi. Identification of hepatitis B virus core mutants by PCR-RFLP in chronic hepatitis B patients from Punjab, Pakistan. Archives of Virology 2008; 153(1): 163 doi: 10.1007/s00705-007-1093-z
|
5 |
Jianghua Wang, Haiying Zhang, Yingjun Zhang, Dong Jiang, Jing Li, Siegfried Goldmann, Qingyun Ren, Ran Fei, Xueyan Wang, Lai Wei. Influences on viral replication and sensitivity to GLS4, a HAP compound, of naturally occurring T109/V124 mutations in hepatitis B virus core protein. Journal of Medical Virology 2017; 89(10): 1804 doi: 10.1002/jmv.24830
|
6 |
Max Q. Arens, Ella M. Swierkosz. Clinical Virology Manual. 2009; : 134 doi: 10.1128/9781555815974.ch12
|
7 |
Mengxin Lin, Ruyi Guo, Cuiping Ma, Dawu Zeng, Zhijun Su. Manganese Breaks the Immune Tolerance of HBs-Ag. Open Forum Infectious Diseases 2021; 8(2) doi: 10.1093/ofid/ofab028
|
8 |
Hui Ma, Xing-Liang Zhao, Xue-Yan Wang, Xing-Wang Xie, Jin-Chao Han, Wen-Li Guan, Qin Wang, Lin Zhu, Xiao-Ben Pan, Lai Wei, Wenyu Lin. 2’,3’-Cyclic Nucleotide 3’-Phosphodiesterases Inhibit Hepatitis B Virus Replication. PLoS ONE 2013; 8(11): e80769 doi: 10.1371/journal.pone.0080769
|
9 |
Max Q. Arens, Ella M. Swierkosz. Manual of Clinical Microbiology. 2011; : 1729 doi: 10.1128/9781555816728.ch110
|
10 |
Quan Zhang, Yan Wang, Lai Wei, Dong Jiang, Jiang Hua Wang, Hui Ying Rao, Ling Zhu, Hongsong Chen, Ran Fei, Xu Cong. Role of ISGF3 in modulating the anti‐hepatitis B virus activity of interferon‐alpha in vitro. Journal of Gastroenterology and Hepatology 2008; 23(11): 1747 doi: 10.1111/j.1440-1746.2007.04985.x
|
11 |
Huguang Chen, Shuya Luo, Weili Lu, Zhi Chen, Jiamin Chen, Shu Zheng, Jiekai Yu. Serum protein expression patterns in detecting a new viral protein in HBeAg‐negative chronic hepatitis B. Journal of Viral Hepatitis 2019; 26(S1): 90 doi: 10.1111/jvh.13166
|
12 |
Yanan Guo, He Lu, Lei Xu, Nur Fazleen Binti Idris, Yimin Li, Jieli Hu, Ailong Huang, Zeng TU. The response of hepatitis B virus genotype to interferon is associated with a mutation in the interferon-stimulated response element. Medicine 2019; 98(51): e18442 doi: 10.1097/MD.0000000000018442
|
13 |
Lawrence Ehis Okoror, Ayodele Oluwaseun Ajayi, Oluwaseun Benjamin Ijalana. Elevated serum β2-microglobulin in individuals coinfected with hepatitis B and hepatitis D virus in a rural settings in Southwest Nigeria. BMC Research Notes 2017; 10(1) doi: 10.1186/s13104-017-3015-9
|
14 |
Jia-Jie Lu, En-Qiang Chen, Jia-Hong Yang, Tao-You Zhou, Li Liu, Hong Tang. A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-10
|
15 |
Xue-Yan Wang, Zhen-Man Wei, Guo-Yi Wu, Jiang-Hua Wang, Ying-Jun Zhang, Jing Li, Heng-Hui Zhang, Xing-Wang Xie, Xian Wang, Zhao-He Wang, Lai Wei, Yu Wang, Hong-Song Chen. In vitro inhibition of HBV replication by a novel compound, GLS4, and its efficacy against adefovir-dipivoxil-resistant HBV mutations. Antiviral Therapy 2012; 17(5): 793 doi: 10.3851/IMP2152
|
16 |
Stephen Locarnini, William S. Mason. Cellular and virological mechanisms of HBV drug resistance. Journal of Hepatology 2006; 44(2): 422 doi: 10.1016/j.jhep.2005.11.036
|